23671-28-5Relevant articles and documents
UREA DERIVATIVES FOR TREATING AND/OR PREVENTING CANCER
-
Page/Page column 26; 28, (2020/05/21)
The present invention relates to a compound or a pharmaceutically acceptable salt thereof of formulae (I) and (II), and a pharmaceutical composition comprising such compound for use for treating a cancer, particularly a cancer overexpressing CXCR1 and CXC
N-heterocyclic ureas as immune regulants
-
, (2008/06/13)
Benzimidazolyl, benzothiazolyl and benzoxazolyl ureas and thioureas are employed as immune regulatory agents, as agents capable of altering the immune response in mammals.